TY  - JOUR
AU  - Butt, Julia
AU  - Jenab, Mazda
AU  - Pawlita, Michael
AU  - Overvad, Kim
AU  - Tjonneland, Anne
AU  - Olsen, Anja
AU  - Boutron-Ruault, Marie-Christine
AU  - Carbonnel, Franck
AU  - Mancini, Francesca Romana
AU  - Kaaks, Rudolf
AU  - Kühn, Tilman
AU  - Boeing, Heiner
AU  - Trichopoulou, Antonia
AU  - Karakatsani, Anna
AU  - Palli, Domenico
AU  - Pala, Valeria Maria
AU  - Tumino, Rosario
AU  - Sacerdote, Carlotta
AU  - Panico, Salvatore
AU  - Bueno-de-Mesquita, Bas
AU  - van Gils, Carla H
AU  - Vermeulen, Roel C H
AU  - Weiderpass, Elisabete
AU  - Quirós, José Ramón
AU  - Duell, Eric Jeffrey
AU  - Sanchez-Perez, Maria-Jose
AU  - Dorronsoro, Miren
AU  - Huerta, José María
AU  - Ardanaz, Eva
AU  - Van Guelpen, Bethany
AU  - Harlid, Sophia
AU  - Perez-Cornago, Aurora
AU  - Gunter, Marc J
AU  - Murphy, Neil
AU  - Freisling, Heinz
AU  - Aune, Dagfinn
AU  - Waterboer, Tim
AU  - Hughes, David J
PY  - 2019
DO  - 10.1158/1055-9965.EPI-19-0313
UR  - http://hdl.handle.net/10668/14470
T2  - Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
AB  - There is a lack of prospective data on the potential association of Fusobacterium nucleatum (F. nucleatum) and colorectal cancer risk. In this study, we assessed whether antibody responses to F. nucleatum are associated with colorectal cancer risk in...
LA  - en
KW  - Colorectal Neoplasms
KW  - Female
KW  - Fusobacterium nucleatum
KW  - Humans
KW  - Prospective Studies
TI  - Antibody Responses to Fusobacterium nucleatum Proteins in Prediagnostic Blood Samples are not Associated with Risk of Developing Colorectal Cancer.
TY  - research article
VL  - 28
ER  -